AMLX: Free Rein (Reign?) in Post-Bariatric Hypoglycemia as Competitor Drops "Further Investment"

研报英文原文证据摘录

AMLX: Free Rein (Reign?) in Post-Bariatric Hypoglycemia as Competitor Drops "Further Investment"

n that we consider

reliable, but we do not represent it is accurate or complete, and it should not be relied on as such. Portions of the research contained herein have been

generated using artificial intelligence ("AI"). We primarily use AI to gather general market or industry data and to compile company-specific information

to facilitate the recipient's preliminary review. In providing this research, we assume that any information obtained from public sources, data suppliers

(including AI systems) and other third parties is reasonable and reliable but acknowledge that any such information (including AI content) could contain

errors, inconsistencies, bias or outdated or irrelevant information. We seek to update our research as appropriate, but various regulations may prevent

us from doing so. Other than certain industry reports published on a periodic basis, the large majority of reports are published at irregular intervals as

appropriate in the research analyst's judgement. Guggenheim Securities conducts a full-service, integrated investment banking and brokerage business.

Guggenheim Securities is a member of SIPC (http://www.sipc.org). Guggenheim Securities' salespeople, traders, and other professionals may provide oral

or written market commentary or trading strategies to Guggenheim Securities' clients and our employees trading for our own account that reflect opinions

that are contrary to the opinions expressed in this research. Guggenheim and certain of our affiliates conduct an investment management business, trade

for their own accounts, and may make investment decisions that are inconsistent with the recommendations or views expressed in this research.